Investors Financial Results

Investors Presentations

Q2 FY 2024-25

pdf-e1638009608816.png

Q1 FY 2024-25

pdf-e1638009608816.png

Investors Day 2024

pdf-e1638009608816.png

Q4 FY 2023-24

pdf-e1638009608816.png

Q3 FY 2023-24

pdf-e1638009608816.png

Q2 FY 2023-24

pdf-e1638009608816.png

Glenmark Pharma announces Proposed Divestment of Majority Stake in Glenmark Life Sciences

pdf-e1638009608816.png

Q1 FY 2023-24

pdf-e1638009608816.png

Q4 FY 2022-23

pdf-e1638009608816.png

Q3 FY 2022-23

pdf-e1638009608816.png

Investors Day 2022

pdf-e1638009608816.png

Q2 FY 2022-23

pdf-e1638009608816.png

Q1 FY 2022-23

pdf-e1638009608816.png

Q4 FY 2021-22

pdf-e1638009608816.png

Q3 FY 2021-22

pdf-e1638009608816.png

Q2 FY 2021-22

pdf-e1638009608816.png

Q1 FY 2021-22

pdf-e1638009608816.png

Q4 FY 2020-21

pdf-e1638009608816.png

Investors Presentations

Q3 FY 2023-24

pdf-e1638009608816.png

Q2 FY 2023-24

pdf-e1638009608816.png

Glenmark Pharma announces Proposed Divestment of Majority Stake in Glenmark Life Sciences

pdf-e1638009608816.png

Q1 FY 2023-24

pdf-e1638009608816.png

Q4 FY 2022-23

pdf-e1638009608816.png

Q3 FY 2022-23

pdf-e1638009608816.png

Investors Day 2022

pdf-e1638009608816.png

Q2 FY 2022-23

pdf-e1638009608816.png

Q1 FY 2022-23

pdf-e1638009608816.png

Q4 FY 2021-22

pdf-e1638009608816.png

Q3 FY 2021-22

pdf-e1638009608816.png

Q2 FY 2021-22

pdf-e1638009608816.png

Q1 FY 2021-22

pdf-e1638009608816.png

Q4 FY 2020-21

pdf-e1638009608816.png
Announcement Icon

LATEST ANNOUNCEMENTS

For Investors and Shareholders

Financial Icon

FINANCIAL RESULTS

Growing from strength to strength

Newsroom

Newsroom

Information on our latest announcements and our media library